These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 24170628)

  • 1. Identification and characterization of Cryptococcus neoformans protein fractions that induce protective immune responses.
    Chaturvedi AK; Weintraub ST; Lopez-Ribot JL; Wormley FL
    Proteomics; 2013 Dec; 13(23-24):3429-41. PubMed ID: 24170628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against Experimental Cryptococcosis following Vaccination with Glucan Particles Containing Cryptococcus Alkaline Extracts.
    Specht CA; Lee CK; Huang H; Tipper DJ; Shen ZT; Lodge JK; Leszyk J; Ostroff GR; Levitz SM
    mBio; 2015 Dec; 6(6):e01905-15. PubMed ID: 26695631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination with Recombinant
    Specht CA; Lee CK; Huang H; Hester MM; Liu J; Luckie BA; Torres Santana MA; Mirza Z; Khoshkenar P; Abraham A; Shen ZT; Lodge JK; Akalin A; Homan J; Ostroff GR; Levitz SM
    mBio; 2017 Nov; 8(6):. PubMed ID: 29184017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methodology for Anti-Cryptococcal Vaccine Development.
    Chaturvedi AK; Wormley FL
    Methods Mol Biol; 2017; 1625():129-140. PubMed ID: 28584988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into the mechanisms of protective immunity against Cryptococcus neoformans infection using a mouse model of pulmonary cryptococcosis.
    Wozniak KL; Ravi S; Macias S; Young ML; Olszewski MA; Steele C; Wormley FL
    PLoS One; 2009 Sep; 4(9):e6854. PubMed ID: 19727388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A proteomic-based approach for the identification of immunodominant Cryptococcus neoformans proteins.
    Young M; Macias S; Thomas D; Wormley FL
    Proteomics; 2009 May; 9(9):2578-88. PubMed ID: 19343717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CARD9 Is Required for Classical Macrophage Activation and the Induction of Protective Immunity against Pulmonary Cryptococcosis.
    Campuzano A; Castro-Lopez N; Martinez AJ; Olszewski MA; Ganguly A; Leopold Wager C; Hung CY; Wormley FL
    mBio; 2020 Jan; 11(1):. PubMed ID: 31911495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Heat-Killed
    Wang Y; Wang K; Masso-Silva JA; Rivera A; Xue C
    mBio; 2019 Nov; 10(6):. PubMed ID: 31772051
    [No Abstract]   [Full Text] [Related]  

  • 9. Induction of Protective Immunity to Cryptococcal Infection in Mice by a Heat-Killed, Chitosan-Deficient Strain of Cryptococcus neoformans.
    Upadhya R; Lam WC; Maybruck B; Specht CA; Levitz SM; Lodge JK
    mBio; 2016 May; 7(3):. PubMed ID: 27165801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective immunity against experimental pulmonary cryptococcosis in T cell-depleted mice.
    Wozniak KL; Young ML; Wormley FL
    Clin Vaccine Immunol; 2011 May; 18(5):717-23. PubMed ID: 21450975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective immunity against pulmonary cryptococcosis is associated with STAT1-mediated classical macrophage activation.
    Hardison SE; Herrera G; Young ML; Hole CR; Wozniak KL; Wormley FL
    J Immunol; 2012 Oct; 189(8):4060-8. PubMed ID: 22984078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of protective inflammation and cell-mediated immunity against Cryptococcus neoformans after exposure to hyphal mutants.
    Zhai B; Wozniak KL; Masso-Silva J; Upadhyay S; Hole C; Rivera A; Wormley FL; Lin X
    mBio; 2015 Oct; 6(5):e01433-15. PubMed ID: 26443458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine potential of cytosolic proteins loaded fibrin microspheres of Cryptococcus neoformans in BALB/c mice.
    Khan AA; Jabeen M; Chauhan A; Owais M
    J Drug Target; 2012 Jun; 20(5):453-66. PubMed ID: 22553959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of host immune responses to pulmonary cryptococcosis using a temperature-sensitive C. neoformans calcineurin A mutant strain.
    Wormley FL; Cox GM; Perfect JR
    Microb Pathog; 2005; 38(2-3):113-23. PubMed ID: 15748813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine-mediated immune responses to experimental pulmonary Cryptococcus gattii infection in mice.
    Chaturvedi AK; Hameed RS; Wozniak KL; Hole CR; Leopold Wager CM; Weintraub ST; Lopez-Ribot JL; Wormley FL
    PLoS One; 2014; 9(8):e104316. PubMed ID: 25119981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective efficacy of antigenic fractions in mouse models of cryptococcosis.
    Mansour MK; Yauch LE; Rottman JB; Levitz SM
    Infect Immun; 2004 Mar; 72(3):1746-54. PubMed ID: 14977983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innate host defenses against Cryptococcus neoformans.
    Hole C; Wormley FL
    J Microbiol; 2016 Mar; 54(3):202-11. PubMed ID: 26920880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucosylceramide Administration as a Vaccination Strategy in Mouse Models of Cryptococcosis.
    Mor V; Farnoud AM; Singh A; Rella A; Tanno H; Ishii K; Kawakami K; Sato T; Del Poeta M
    PLoS One; 2016; 11(4):e0153853. PubMed ID: 27082428
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Colombo AC; Rella A; Normile T; Joffe LS; Tavares PM; de S Araújo GR; Frases S; Orner EP; Farnoud AM; Fries BC; Sheridan B; Nimrichter L; Rodrigues ML; Del Poeta M
    mBio; 2019 Apr; 10(2):. PubMed ID: 30940711
    [No Abstract]   [Full Text] [Related]  

  • 20. STAT1 signaling is essential for protection against Cryptococcus neoformans infection in mice.
    Leopold Wager CM; Hole CR; Wozniak KL; Olszewski MA; Wormley FL
    J Immunol; 2014 Oct; 193(8):4060-71. PubMed ID: 25200956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.